Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
1220033-11-3 | 3-((2,4-Dichlorobenzyl)oxy)pyrrolidine HCl | AA0016HD | MFCD13561014
501-13-3 | N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide | AA0037OW | MFCD01736565
110199-16-1 | (R)-4-Isopropyl-1,3-thiazolidine-2-thione | AA007DQE | MFCD06658213
1016690-06-4 | 1-(4-Ethylphenyl)piperidin-4-one | AA009O43 | MFCD09929586
37663-46-0 | 3H-Spiro[isobenzofuran-1,4'-piperidin]-3-one | AA00CKVI | MFCD11045415
849950-56-7 | Rhodium(1+), [(1,2,5,6-h)-1,5-cyclooctadiene][tricyclo[8.2.2.24,7]hexadeca-4,6,10,12, 13,15-hexaene-5,11-diylbis[diphenylphosphine-kP]]-, tetrafluoroborate(1-) | AA00G50B | MFCD16294983
26878-13-7 | Methyl 2-oxo-2-(thiophen-2-yl)acetate | AA00I509 | MFCD19313480
959238-47-2 | 4-(Trifluoromethyl)indolin-2-one | AA019FX8 | MFCD09954926
1087788-82-6 | 2,2,2-trifluoroethyl N-(4-methanesulfonylphenyl)carbamate | AA019QQZ | MFCD11099839
1105059-12-8 | N-[2-(4-fluorophenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | AA019UN0 | MFCD09935805
